Schedule 13G ownership disclosure

NovaBay Pharmaceuticals Inc

Common Stock, par value $0.01 par value · CUSIP: 66987P409

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Poplar Point Capital Management LLC

    Shares: 971,654.00 · Class: 16.71%

  • Poplar Point Capital Partners LP

    Shares: 971,654.00 · Class: 16.71%

  • Poplar Point Capital GP LLC

    Shares: 971,654.00 · Class: 16.71%

  • Jad Fakhry

    Shares: 971,654.00 · Class: 16.71%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001398344-25-009469
Form type
SCHEDULE 13G/A
Filer
Stablecoin Development Corp
CIK
CIK 1389545
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub